Innate Immunity and Herpes Simplex Infection
先天免疫和单纯疱疹感染
基本信息
- 批准号:7914345
- 负责人:
- 金额:$ 182.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-14 至 2012-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The discovery of the Toll-Like Receptor Proteins (TLRs) and their importance in the regulation of host response to infection has led to a series of investigations related to the role of host proteins and cytokines in microbial pathogenesis. Recent work has demonstrated that not only do these TLRs function as cell surface receptors for foreign antigens, but also that TLRs (especially TLR 3, 7, 8 and 9) are endosomally localized and they recognize infectious agents (particularly viruses and viral nucleic acids). In addition to the TLRs, the production of type 1 interferons (IFNs) has been shown to be regulated by cytoplasmic RNA helicase proteins, like RIG-I and Mda-5, and by inflammosame proteins like NLRP-3 (or NALP-3, Cryopyrin) which are related to the NOD family of proteins. Several Interferon Regulatory Factors (IRFs), which control the production of type I IFNs, have been implicated downstream of these different viral sensing pathways. The overall hypothesis of the Project is that pattern recognition proteins respond to particular viral antigens and that those responses are regulated by other viral proteins and it is the effect of the host cytokines induced as a result of this interaction that determines the pathogenic potential of a virus. Project 1 (Kurt-Jones) will define the role of TLRs in HSV induced inflammatory responses and viral pathogenesis and how IRF-1 signaling regulates these responses. Project 2 (Fitzgerald) will define the role of IL-I, NLRP-3, and TLR-independent DNA sensors in the virus-induced production of inflammatory cytokines and type I interferons, and the control of anti-viral immunity. Project 3 (Knipe) will define how certain viral proteins regulate TLR signaling and TLR adapters (and other pattern recognition proteins) and affect the secretion of interferon and cytokines. Project 4 (Finberg) will examine how recently defined polymorphisms in TLRs and other host genes important in innate immunity, affect reactivation of HSV. All Projects involve the use of common reagents and the definition of new paradigms related to recognition and response of the host to HSV.
描述(由申请人提供):Toll样受体蛋白(TLR)的发现及其在调节宿主对感染的反应中的重要性导致了一系列与宿主蛋白和细胞因子在微生物发病机制中的作用相关的研究。最近的工作已经证明,不仅这些TLR作为外源抗原的细胞表面受体起作用,而且TLR(特别是TLR 3、7、8和9)是内体定位的,并且它们识别感染因子(特别是病毒和病毒核酸)。除了TLR之外,1型干扰素(IFN)的产生已显示受细胞质RNA解旋酶蛋白如RIG-I和Mda-5以及炎性蛋白如NLRP-3(或NALP-3,Cryopyrin)调节,所述炎性蛋白与NOD蛋白家族相关。控制I型IFN产生的几种干扰素调节因子(IRF)已经涉及这些不同病毒传感途径的下游。该项目的总体假设是,模式识别蛋白对特定病毒抗原做出反应,并且这些反应受其他病毒蛋白的调节,并且正是由于这种相互作用而诱导的宿主细胞因子的作用决定了病毒的致病潜力。项目1(Kurt-Jones)将定义TLR在HSV诱导的炎症反应和病毒发病机制中的作用,以及IRF-1信号传导如何调节这些反应。项目2(Fitzgerald)将确定IL-1、NLRP-3和TLR非依赖性DNA传感器在病毒诱导的炎性细胞因子和I型干扰素产生中的作用,以及抗病毒免疫的控制。项目3(Alfreppe)将定义某些病毒蛋白如何调节TLR信号和TLR适配器(以及其他模式识别蛋白),并影响干扰素和细胞因子的分泌。项目4(Finberg)将研究最近定义的TLR和其他先天免疫重要宿主基因的多态性如何影响HSV的再激活。所有项目都涉及使用通用试剂和定义与宿主对HSV的识别和反应相关的新范例。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
Inflammasomes and anti-viral immunity.
炎症小体和抗病毒免疫。
- DOI:10.1007/s10875-010-9431-4
- 发表时间:2010
- 期刊:
- 影响因子:9.1
- 作者:Rathinam,VijayAK;Fitzgerald,KatherineA
- 通讯作者:Fitzgerald,KatherineA
Dicer's role as an antiviral: still an enigma.
- DOI:10.1016/j.coi.2013.10.015
- 发表时间:2014-02
- 期刊:
- 影响因子:7
- 作者:MacKay CR;Wang JP;Kurt-Jones EA
- 通讯作者:Kurt-Jones EA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert William Finberg其他文献
Robert William Finberg的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert William Finberg', 18)}}的其他基金
International Immunocompromised Host Society's 19th International Symposium on Infections in the Immunocompromised Host
国际免疫低下宿主协会第十九届国际免疫低下宿主感染研讨会
- 批准号:
9260163 - 财政年份:2016
- 资助金额:
$ 182.82万 - 项目类别:
18th International Symposium on Infections in the Immunocompromised Host
第18届免疫低下宿主感染国际研讨会
- 批准号:
8720337 - 财政年份:2014
- 资助金额:
$ 182.82万 - 项目类别:
17th International Symposium on Infections in the Immunocompromised Host
第十七届免疫低下宿主感染国际研讨会
- 批准号:
8330069 - 财政年份:2012
- 资助金额:
$ 182.82万 - 项目类别:
Toll2011 Meeting, Decoding Innate Immunity
Toll2011会议,解码先天免疫
- 批准号:
8130053 - 财政年份:2011
- 资助金额:
$ 182.82万 - 项目类别:
16th Symposium on Infections in the Immunocompromised Host
第16届免疫低下宿主感染研讨会
- 批准号:
7994945 - 财政年份:2010
- 资助金额:
$ 182.82万 - 项目类别:
Innate Immunity and Herpes Simplex Pathogensis
先天免疫和单纯疱疹发病机制
- 批准号:
7877330 - 财政年份:2009
- 资助金额:
$ 182.82万 - 项目类别:
相似海外基金
Mechanisms of endogenous retrovirus-mediated antiviral immunity against genital herpes simplex virus 2 infection and disease.
内源性逆转录病毒介导的针对生殖器单纯疱疹病毒2感染和疾病的抗病毒免疫机制。
- 批准号:
463342 - 财政年份:2022
- 资助金额:
$ 182.82万 - 项目类别:
Operating Grants
FCGRIIIA and IGHG (GM) Genotypes and Immunity to HSV1 in Herpes Stromal Keratitis
疱疹性基质性角膜炎中的 FCGRIIIA 和 IGHG (GM) 基因型以及对 HSV1 的免疫
- 批准号:
10675575 - 财政年份:2022
- 资助金额:
$ 182.82万 - 项目类别:
Prize 202203PJT - Mechanisms of endogenous retrovirus-mediated antiviral immunity against genital herpes simplex virus 2 infection and disease.
奖 202203PJT - 内源性逆转录病毒介导的针对生殖器单纯疱疹病毒 2 感染和疾病的抗病毒免疫机制。
- 批准号:
467989 - 财政年份:2022
- 资助金额:
$ 182.82万 - 项目类别:
Operating Grants
FCGRIIIA and IGHG (GM) Genotypes and Immunity to HSV1 in Herpes Stromal Keratitis
疱疹性基质性角膜炎中的 FCGRIIIA 和 IGHG (GM) 基因型以及对 HSV1 的免疫
- 批准号:
10507311 - 财政年份:2022
- 资助金额:
$ 182.82万 - 项目类别:
A vaccine for genital herpes that achieves sterilizing immunity
实现绝育免疫力的生殖器疱疹疫苗
- 批准号:
10375434 - 财政年份:2019
- 资助金额:
$ 182.82万 - 项目类别:
Mucosal Chemokines and CD8+ T Cell Immunity to Genital Herpes
粘膜趋化因子和 CD8 T 细胞对生殖器疱疹的免疫
- 批准号:
10223136 - 财政年份:2019
- 资助金额:
$ 182.82万 - 项目类别:
Mucosal Chemokines and CD8+ T Cell Immunity to Genital Herpes
粘膜趋化因子和 CD8 T 细胞对生殖器疱疹的免疫
- 批准号:
10450154 - 财政年份:2019
- 资助金额:
$ 182.82万 - 项目类别:
A vaccine for genital herpes that achieves sterilizing immunity
实现绝育免疫力的生殖器疱疹疫苗
- 批准号:
9915856 - 财政年份:2019
- 资助金额:
$ 182.82万 - 项目类别:
Prevention strategy of Herpes zoster based on analysis of reconstruction of cell-mediated immunity after hematopoietic cell transplantation
基于造血细胞移植后细胞免疫重建分析的带状疱疹预防策略
- 批准号:
18K08320 - 财政年份:2018
- 资助金额:
$ 182.82万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Anti-viral immunity and the survival of cells infected with herpes simplex virus in vivo
抗病毒免疫与体内单纯疱疹病毒感染细胞的存活
- 批准号:
nhmrc : 1005846 - 财政年份:2011
- 资助金额:
$ 182.82万 - 项目类别:
NHMRC Project Grants